Viewing StudyNCT00104975



Ignite Creation Date: 2024-05-05 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00104975
Status: COMPLETED
Last Update Posted: 2016-12-15
First Post: 2005-03-03

Brief Title: Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Sponsor: Yale University
Organization: Yale University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-02
Start Date Type: None
Primary Completion Date: 2008-05
Primary Completion Date Type: ACTUAL
Completion Date: 2008-05
Completion Date Type: ACTUAL
First Submit Date: 2005-03-03
First Submit QC Date: March 3 2005
Study First Post Date: 2005-03-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-12-13
Last Update Post Date: 2016-12-15
Last Update Post Date Type: ESTIMATED